The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "heart"

Search results for: heart

Heart to Heart: Cardiovascular Disease in Autoimmune Conditions

December 2, 2021 • By Jason Liebowitz, MD

During the ACR Convergence 2021 Review Course, Joan Bathon, MD, discussed cardiovascular manifestations of autoimmune diseases, including rheumatoid arthritis.... [Read More]

Filed Under: ACR Convergence, Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: ACR Convergence 2021, ACR Convergence 2021 – RA, Cardiovascular disease

Myositis & the Heart: New Perspectives on the Pathogenesis & Management of Cardiac Involvement in Myositis

February 18, 2021 • By Carina Stanton

Experts discuss the diagnosis and treatment of myositis-related cardiovascular disease.... [Read More]

Filed Under: ACR Convergence, Conditions, Meeting Reports Tagged With: ACR Convergence 2020, cardiovascular, heart, Heart Disease, myocarditis, myositis

Study Finds NSAIDs Raise Heart Disease Risk in Osteoarthritis Patients

February 16, 2021 • By Susan Bernstein

In a controlled, large-cohort, longi­tudinal study from Canada, Atiquazzaman et al. found that use of non-steroidal anti-inflammatory drugs (NSAIDs) substantially contributes to increased cardiovascular disease risk among people with osteoarthritis (OA).1  This is the first study to evaluate the mediating role that NSAIDs play in the association between OA and cardiovascular disease (CVD), and the… [Read More]

Filed Under: Conditions, Osteoarthritis, Research Reviews Tagged With: Cardiovascular disease, Nonsteroidal anti-inflammatory drugs (NSAIDs)

Coronary Microvascular Dysfunction May Predict Heart Disease in Rheumatoid Arthritis

December 14, 2020 • By Kurt Ullman

Cardiovascular disease (CVD) is a leading cause of death in patients with rheumatoid arthritis (RA). Patients with RA have a 1.5 times increased risk for heart attack compared with the general population. Although the treatment of RA has advanced significantly, the ability to prevent cardiovascular events hasn’t followed. A study in Arthritis Care & Research… [Read More]

Filed Under: Conditions, Research Reviews, Rheumatoid Arthritis Tagged With: Cardiovascular disease, coronary microvascular disease, RA Resource Center

Dual-Energy CT May Help Detect Gout Patients at Risk for Heart Disease

September 25, 2019 • By Marilynn Larkin

NEW YORK (Reuters Health)—Dual energy computed tomography (DECT) can differentiate cardiovascular monosodium urate (MSU) deposits from calcium deposits in patients with gout, potentially identifying those at risk of heart disease, researchers say. Sylvia Strobl, MD, of Medical University Innsbruck and colleagues analyzed calcium scores and MSU deposits in 59 patients with gout (mean age: 59;… [Read More]

Filed Under: Conditions, Crystal Arthritis Tagged With: cardiovascular, dual energy computed tomography, Gout, Heart Disease, imaging

FDA Rejects Novartis Bid to Repurpose Inflammation Drug for Heart Attacks

October 22, 2018 • By John Miller

ZURICH (Reuters)—The U.S. Food and Drug Administration (FDA) has rejected Novartis’s bid to repurpose a drug now approved for rare inflammatory diseases to be used in a group of heart attack survivors, according to the Swiss drugmaker. The company received an FDA letter turning down its bid to make canakinumab a targeted therapy for those… [Read More]

Filed Under: Drug Updates Tagged With: canakinumab, cardiovascular, Familial Mediterranean fever, FDA, heart, Novartis, U.S. Food and Drug Administration (FDA)

Heart of a Champion: The 2018 ACR/ARHP Annual Meeting Kicks Off with Dramatic Keynote

October 21, 2018 • By Keri Losavio

“You’re probably going to die tonight. You should call your family.” Jonathan Koch, president and CCO of Asylum Entertainment LLC, told his touching and inspiring story of mysterious illness, resilience and recovery in the keynote presentation of the 2018 ACR/ARHP Annual Meeting.... [Read More]

Filed Under: American College of Rheumatology, Meeting Reports Tagged With: 2018 ACR/ARHP Annual Meeting, Association of Rheumatology Professionals (ARP), Daikh, Koch

Drug Safety: Fasinumab Evaluated in Clinical Trials, Plus Celecoxib May Not Pose Increased Heart Attack or Stroke Risk

May 15, 2018 • By Michele B. Kaufman, PharmD, BCGP

After an independent review, ongoing clinical trials investigating the safety of fasinumab for treating hip or knee OA will discontinue the use of higher fasinumab doses…... [Read More]

Filed Under: Drug Updates, Safety Tagged With: celecoxib, Drug Safety, fasinumab, FDA, hip, knee, Knee Osteoarthritis (OA), Nonsteroidal anti-inflammatory drugs (NSAIDs), Pain, Pain Management, U.S. Food and Drug Administration (FDA)

Study Finds Newer Gout Drug Poses Risk to Heart Patients

March 12, 2018 • By Gene Emery

(Reuters Health)—Gout sufferers with major pre-existing heart disease face a higher risk of death if they are treated with the drug febuxostat, a large long-term study has concluded. The risk of death from cardiovascular disease was 34% higher with febuxostat than with allopurinol. When researchers considered deaths from any cause, the risk was 22% higher… [Read More]

Filed Under: Conditions, Crystal Arthritis Tagged With: Allopurinol, Cardiovascular disease, Febuxostat, Gout, Heart Disease, stroke

FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval

March 7, 2018 • By Michele B. Kaufman, PharmD, BCGP

After reviewing a 10-year study, the FDA cautions that prescribing clarithromycin to patients with heart disease increases the risk of heart problems or death…... [Read More]

Filed Under: Drug Updates, Pharma Co. News, Safety Tagged With: acute pain, antibiotics, Apadaz, clarithromycin, Heart Disease

  • 1
  • 2
  • 3
  • …
  • 88
  • Next Page »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)